表紙
市場調查報告書

封閉式藥物轉移系統

Closed System Drug Transfer Devices

出版商 Greystone Research Associates 商品編碼 135878
出版日期 內容資訊 英文
商品交期: 最快1-2個工作天內
價格
Back to Top
封閉式藥物轉移系統 Closed System Drug Transfer Devices
出版日期: 2017年12月01日內容資訊: 英文
簡介

認定對人類有害的藥物施給,為能明確理解該物質的危險性而詳查量增加。最前線治療領域為臨床腫瘤學,進行減輕暴露於細胞毒性醫藥品的嘗試。

本報告提供腫瘤的治療市場上細胞毒性醫藥品的影響與安全性調查分析、市場趨勢與人口動態、封閉式藥物轉移產品分析、需求推動因素、競爭要素驗證、主要企業、產品開發、商務策略等相關的系統性資訊。

摘要整理

細胞毒性醫藥品的治療市場趨勢

  • 治療趨勢與問題點
  • 注射型/點滴型抗癌藥物的施給
  • 醫藥品包裝和給藥技術
  • 封閉式藥物轉移市場推動因素
  • 競爭情形
  • 危險因素

封閉式藥物轉移的設計因素

  • 主要的系統設計因素
  • 人因工程/人體工學
  • 物質選擇的問題點
  • 藥物的重組與稀釋
  • 癌症治療藥的安全性
  • 癌症治療藥的給藥和用量
  • 各藥物的用量設定和個人的用量設定

封閉式藥物轉移 - 商用設備的評估與市場資料

  • ChemoCLAVE
  • EquaShield
  • OnGuard
  • PhaSeal
  • Texium/SmartSite
  • 其他封閉式藥物轉移設備

市場因素

  • 法規上的問題點
  • 看護者的適合性
  • 複雜的層級與易用性
  • 醫療經濟
  • 經營模式與策略

市場評估與預測

  • 北美
  • 歐洲
  • 亞洲
  • 其他地區市場

封閉式藥物轉移 - 市場參與企業簡介

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: DTS555D17

Interest in closed system drug transfer devices has been growing as regulatory activity and practitioner awareness surrounding hazardous drug compounding and administration continue to increase. Drugs deemed hazardous to humans has been receiving increasing amounts of scrutiny in recent years as the dangers of these substances become more clearly understood. For caregivers and their patients, the therapeutic area that is at the forefront of attempts to mitigate exposure to cytotoxic drugs is clinical oncology, a field that - in spite of promising new drugs based on therapeutic antibodies - continues to rely heavily on antineoplastics, a class that includes alkylating agents and antimetabolites, to treat a wide range of cancers. Regulatory and industry efforts to create standards and procedures for closed system drug transfer devices are designed to protect workers and patients from accidental and incidental exposure to cytotoxics are being driven by data that suggests a causal link between exposure and health issues. This report analyzes devices, regulations, markets and participants competing in the closed system drug transfer device segment and provides insight, analysis, assessments and forecasts to assist readers in navigating this rapidly evolving sector.

Closed System Drug Transfer Devices - What You Will Learn:

  • What are the key segments and addressable markets that comprise the market for cytotoxic drug delivery?
  • What are the major therapeutic demand drivers for cytotoxic drug therapeutics?
  • What are the design factors and technologies that are being used in commercial and development-stage closed drug transfer systems?
  • What is the market share and product position in the market and what will it look like in 2024?
  • Who are the companies behind the current generation of cytotoxic transfer devices and what are their business models?
  • What is the role of pharma-device alliances and design partnerships in the commercialization and market access of new and emerging closed system drug transfer devices?
  • What is the impact of economic, technology, and regulatory factors on CSDT device demand?

Table of Contents

Summary of Contents

Evolution in Oncology Therapeutics

  • Recombinant Drugs & Personalized Medicine
  • The Growth of Targeted Therapeutics
  • The Evolving Role of Cytotoxic Drugs
  • The Administration of Antineoplastics
  • Closed System Drug Transfer (CSDT) Demand Drivers
  • Regulatory Factors
  • Market Factors
  • Technology Factors
  • Regional Factors
  • CSDT Competitive Landscape
  • Risks and Opportunities

The Market for Cytotoxic Drugs

  • Usage Trends
  • Evolving Prescribing Factors
  • Special Considerations

Closed System Drug Transfer Design Factors

  • Oncology Therapeutics Medication Safety
  • Material Selection Issues
  • Drug Reconstitution
  • Oncology Drug Administration and Dosing
  • Drug-Specific Dosing Modification and Individualized Dosing
  • CSDT Device Performance Factors
  • Vapor Containment
  • Testing Protocols

CSDT Devices - Key Market Segments

  • Teaching Hospitals
  • Regional Hospital
  • Oncology Centers/Clinics

Closed System Drug Transfer - Device Assessments

  • Device Configuration
  • Device-to-Device interface
  • User-to-Device Interface
  • Device Sharps Strategy
  • Device Compliance Performance

Market Factors

  • Regulations and Standards
  • CDC/NIOSH
  • HOPA
  • ISMP
  • USP 800
  • ISOPP
  • Caregiver Compliance
  • Level of Complexity and Ease of Use
  • Healthcare Economics
  • Business Models and Strategies

Market Assessments and Forecasts

  • North America
  • Europe
  • Asia
  • Other Geographic Markets

Company Profiles

Back to Top